1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Escherichia Coli Infections Global Clinical Trials Review, H1, 2015

Escherichia Coli Infections Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Escherichia Coli Infections Global Clinical Trials Review, H1, 2015" provides an overview of Escherichia Coli Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Escherichia Coli Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Escherichia Coli Infections Global Clinical Trials Review, H1, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Escherichia Coli Infections 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Escherichia Coli Infections to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Unaccomplished Trials of Escherichia Coli Infections 22
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Escherichia Coli Infections Therapeutics Clinical Trials 27
Prominent Drugs 28
Clinical Trial Profiles 29
Clinical Trial Overview of Top Companies 29
Teijin Limited 29
Clinical Trial Overview of Teijin Limited 29
NIZO food research BV 30
Clinical Trial Overview of NIZO food research BV 30
Bellus Health Inc. 31
Clinical Trial Overview of Bellus Health Inc. 31
Thallion Pharmaceuticals Inc. (Inactive) 32
Clinical Trial Overview of Thallion Pharmaceuticals Inc. (Inactive) 32
Pfizer Inc. 33
Clinical Trial Overview of Pfizer Inc. 33
GlaxoSmithKline Plc 34
Clinical Trial Overview of GlaxoSmithKline Plc 34
Cubist Pharmaceuticals, Inc. 35
Clinical Trial Overview of Cubist Pharmaceuticals, Inc. 35
Berna Biotech Ltd 36
Clinical Trial Overview of Berna Biotech Ltd 36
Arla Foods amba 37
Clinical Trial Overview of Arla Foods amba 37
Alexion Pharmaceuticals, Inc. 38
Clinical Trial Overview of Alexion Pharmaceuticals, Inc. 38
Clinical Trial Overview of Top Institutes / Government 39
The National Institute of Allergy and Infectious Diseases 39
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 39
Assistance Publique - Hopitaux de Paris 40
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 40
Medical University of Vienna 41
Clinical Trial Overview of Medical University of Vienna 41
The Hong Kong Polytechnic University 42
Clinical Trial Overview of The Hong Kong Polytechnic University 42
Uppsala University 43
Clinical Trial Overview of Uppsala University 43
Five Key Clinical Profiles 44
Appendix 71
Abbreviations 71
Definitions 71
Research Methodology 72
Secondary Research 72
About GlobalData 73
Contact Us 73
Disclaimer 73
Source 74

List of Tables
Escherichia Coli Infections Therapeutics, Global, Clinical Trials by Region, 2015* 7
Escherichia Coli Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Escherichia Coli Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Escherichia Coli Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Escherichia Coli Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Escherichia Coli Infections Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Escherichia Coli Infections Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Escherichia Coli Infections Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Escherichia Coli Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 15
Escherichia Coli Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Escherichia Coli Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Escherichia Coli Infections Therapeutics, Global, Clinical Trials by Phase, 2015* 18
Escherichia Coli Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 19
Escherichia Coli Infections Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20
Escherichia Coli Infections Therapeutics Clinical Trials, Global, by End Point Status, 2015* 21
Escherichia Coli Infections Therapeutics, Global, Suspended Clinical Trials, 2015* 22
Escherichia Coli Infections Therapeutics, Global, Terminated Clinical Trials, 2015* 23
Escherichia Coli Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24
Escherichia Coli Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 25
Escherichia Coli Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26
Escherichia Coli Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 27
Escherichia Coli Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 28
Escherichia Coli Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Teijin Limited, 2015* 29
Escherichia Coli Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by NIZO food research BV, 2015* 30
Escherichia Coli Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Bellus Health Inc., 2015* 31
Escherichia Coli Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Thallion Pharmaceuticals Inc. (Inactive), 2015* 32
Escherichia Coli Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 33
Escherichia Coli Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015* 34
Escherichia Coli Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Cubist Pharmaceuticals, Inc., 2015* 35
Escherichia Coli Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Berna Biotech Ltd, 2015* 36
Escherichia Coli Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Arla Foods amba, 2015* 37
Escherichia Coli Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Alexion Pharmaceuticals, Inc., 2015* 38
Escherichia Coli Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2015* 39
Escherichia Coli Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2015* 40
Escherichia Coli Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2015* 41
Escherichia Coli Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by The Hong Kong Polytechnic University, 2015* 42
Escherichia Coli Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Uppsala University, 2015* 43

List of Figures
Escherichia Coli Infections Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Escherichia Coli Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Escherichia Coli Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Escherichia Coli Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Escherichia Coli Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Escherichia Coli Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Escherichia Coli Infections Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Escherichia Coli Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 15
Escherichia Coli Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Escherichia Coli Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Escherichia Coli Infections Therapeutics, Global, Clinical Trials by Phase (%), 2015* 18
Escherichia Coli Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 19
Escherichia Coli Infections Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20
Escherichia Coli Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24
Escherichia Coli Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 25
Escherichia Coli Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26
Escherichia Coli Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 27
Escherichia Coli Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 28
GlobalData Methodology 72

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.